Danish govt rolls out the ‘red carpet’ for pharma production companies

4 November 2024

The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies.

It shows how important the industry is to the Danish economy - and can be for Norway if the government follows the Danes' example, says Leif Rune Skymoen, chief executive of Lif - the Pharmaceutical Industry Association in Denmark.

With new measures, the Danish government will make it easier to establish production facilities in Denmark. A total of 102.4 million Danish kroner ($14.9 million) is set aside for red carpets for production companies in the period 2024-2027. The measures are linked to the upcoming Danish Life science strategy.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical